Analysts Set Owens & Minor, Inc. (NYSE:OMI) Price Target at $23.29

Shares of Owens & Minor, Inc. (NYSE:OMIGet Free Report) have received a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $23.29.

A number of analysts have commented on the company. Leerink Partnrs reissued a “market perform” rating on shares of Owens & Minor in a report on Monday, February 26th. StockNews.com lowered Owens & Minor from a “buy” rating to a “hold” rating in a research report on Thursday, May 23rd. SVB Leerink initiated coverage on shares of Owens & Minor in a report on Monday, February 26th. They set a “market perform” rating and a $24.00 price target on the stock. Barclays boosted their price objective on shares of Owens & Minor from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Wednesday, February 21st. Finally, Robert W. Baird dropped their target price on shares of Owens & Minor from $28.00 to $24.00 and set a “neutral” rating on the stock in a report on Monday, May 6th.

Read Our Latest Analysis on Owens & Minor

Owens & Minor Trading Down 1.5 %

Shares of NYSE OMI opened at $17.10 on Tuesday. The stock has a market cap of $1.31 billion, a P/E ratio of -33.53, a price-to-earnings-growth ratio of 0.56 and a beta of 0.33. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.16 and a quick ratio of 0.56. Owens & Minor has a 1 year low of $13.64 and a 1 year high of $28.35. The firm has a 50-day moving average of $21.43 and a 200 day moving average of $21.71.

Owens & Minor (NYSE:OMIGet Free Report) last posted its quarterly earnings results on Friday, May 3rd. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.02. The firm had revenue of $2.61 billion during the quarter, compared to analyst estimates of $2.61 billion. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. Owens & Minor’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.05 EPS. As a group, sell-side analysts expect that Owens & Minor will post 1.53 EPS for the current fiscal year.

Insider Buying and Selling at Owens & Minor

In other news, SVP Jonathan A. Leon sold 5,000 shares of the business’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the sale, the senior vice president now owns 84,673 shares of the company’s stock, valued at approximately $2,103,277.32. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Owens & Minor news, EVP Heath H. Galloway sold 2,031 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $20.18, for a total value of $40,985.58. Following the completion of the transaction, the executive vice president now directly owns 56,898 shares in the company, valued at approximately $1,148,201.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jonathan A. Leon sold 5,000 shares of Owens & Minor stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the sale, the senior vice president now owns 84,673 shares in the company, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 36,923 shares of company stock valued at $686,911. Insiders own 2.62% of the company’s stock.

Institutional Trading of Owens & Minor

Several hedge funds have recently bought and sold shares of OMI. Deerfield Management Company L.P. Series C grew its holdings in Owens & Minor by 35.6% during the 3rd quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock valued at $103,990,000 after buying an additional 1,690,000 shares in the last quarter. FMR LLC raised its stake in Owens & Minor by 10.6% during the third quarter. FMR LLC now owns 11,479,209 shares of the company’s stock valued at $185,504,000 after purchasing an additional 1,103,275 shares in the last quarter. Deutsche Bank AG lifted its position in Owens & Minor by 278.0% during the third quarter. Deutsche Bank AG now owns 694,248 shares of the company’s stock valued at $11,219,000 after purchasing an additional 510,596 shares during the last quarter. Norges Bank purchased a new position in shares of Owens & Minor in the 4th quarter worth $9,160,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Owens & Minor by 8.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,210,991 shares of the company’s stock worth $81,148,000 after buying an additional 327,002 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

(Get Free Report

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Stories

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.